Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1985 7
1986 1
1989 1
1990 5
1994 2
1995 1
1996 1
1997 1
2000 1
2001 1
2002 1
2003 5
2004 10
2005 7
2006 5
2007 11
2008 11
2009 7
2010 9
2011 12
2012 17
2013 22
2014 23
2015 15
2016 9
2017 11
2018 9
2019 9
2020 3
2021 5
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

202 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and Management of Primary Biliary Cholangitis.
Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. Younossi ZM, et al. Among authors: jacobson im. Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3. Am J Gastroenterol. 2019. PMID: 30429590 Review.
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS, Stanca CM, Figueroa Diaz V, Yuan S, Dagher NN, Sarkar SA, Theise ND, Kim S, Shanbhogue K, Jacobson IM. Faruqui S, et al. Among authors: jacobson im. Am J Gastroenterol. 2021 Jul 1;116(7):1414-1425. doi: 10.14309/ajg.0000000000001264. Am J Gastroenterol. 2021. PMID: 33993134
Editorial: bodybuilders beware.
Feldman DM, Jacobson IM. Feldman DM, et al. Among authors: jacobson im. Aliment Pharmacol Ther. 2019 Jun;49(12):1530. doi: 10.1111/apt.15270. Aliment Pharmacol Ther. 2019. PMID: 31134650 No abstract available.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, Abergel A, Mangia A, Lai CL, Chan HL, Mazzotta F, Moreno C, Yoshida E, Shafran SD, Towner WJ, Tran TT, McNally J, Osinusi A, Svarovskaia E, Zhu Y, Brainard DM, McHutchison JG, Agarwal K, Zeuzem S; ASTRAL-1 Investigators. Feld JJ, et al. Among authors: jacobson im. N Engl J Med. 2015 Dec 31;373(27):2599-607. doi: 10.1056/NEJMoa1512610. Epub 2015 Nov 16. N Engl J Med. 2015. PMID: 26571066 Free article. Clinical Trial.
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Marcellin P, et al. Among authors: jacobson im. Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10. Lancet. 2013. PMID: 23234725 Clinical Trial.
Hepatitis C-A clinical review.
Wang LS, D'Souza LS, Jacobson IM. Wang LS, et al. Among authors: jacobson im. J Med Virol. 2016 Nov;88(11):1844-55. doi: 10.1002/jmv.24554. Epub 2016 Apr 29. J Med Virol. 2016. PMID: 27097298 Review.
Fenofibrate-induced cirrhosis.
Ahmed F, Petrovic L, Rosen E, Gonzalez R, Jacobson IM. Ahmed F, et al. Among authors: jacobson im. Dig Dis Sci. 2005 Feb;50(2):312-3. doi: 10.1007/s10620-005-1600-6. Dig Dis Sci. 2005. PMID: 15745090 Review. No abstract available.
Cardiovascular diseases and the liver.
Weisberg IS, Jacobson IM. Weisberg IS, et al. Among authors: jacobson im. Clin Liver Dis. 2011 Feb;15(1):1-20. doi: 10.1016/j.cld.2010.09.010. Clin Liver Dis. 2011. PMID: 21111990 Review.
Emerging therapies for the treatment of hepatitis C.
Lange CM, Jacobson IM, Rice CM, Zeuzem S. Lange CM, et al. Among authors: jacobson im. EMBO Mol Med. 2014 Jan;6(1):4-15. doi: 10.1002/emmm.201303131. EMBO Mol Med. 2014. PMID: 24106239 Free PMC article. Review.
202 results